CD8A and neoplasm: Our results proved that ISV with FOLactis increased cross-presentation drastically due to the higher proportion of activated DCs especially CD103+ and CD8+ DCs in TME and TDLNs, which further induced CD8+ T cell antitumour immunity and led to abscopal tumor regressions.